Tr1X is a private, clinical-stage biotechnology company specializing in the development of novel regulatory T cell-based products to treat autoimmune and inflammatory diseases. Founded by industry experts, Tr1X focuses on creating off-the-shelf allogeneic cell therapies that mimic natural Tr1 cells to restore immune tolerance. As the first company to use engineered Tr1 cell therapy in clinical trials, Tr1X is headquartered in San Diego, CA.
Tr1X is seeking a Vice President, Head of Clinical Operations to serve as a core member of the Management Leadership Team. The VPCO will lead the clinical operations function, ensuring strategic direction, operational excellence, and compliance across all clinical programs. This role requires expertise in clinical trials, vendor management, budgeting, and regulatory adherence, with a focus on patient safety and program scalability.
Tr1X is a private, clinical-stage biotechnology company specializing in the development of novel regulatory T cell-based products to treat autoimmune and inflammatory diseases. Founded by industry experts, Tr1X focuses on creating off-the-shelf allogeneic cell therapies that mimic natural Tr1 cells to restore immune tolerance. As the first company to use engineered Tr1 cell therapy in clinical trials, Tr1X is headquartered in San Diego, CA.
Revolution Medicines